Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RD0Y
|
|||
| Former ID |
DIB004049
|
|||
| Drug Name |
RetinoStat
|
|||
| Synonyms |
AngiStat; XiaGen; Cardiovascular disease therapy, Oxford Biomedica; Gene therapy (HRE), Oxford Biomedica; Angiostatin/endostatin gene therapy (LentiVector, AMD), Oxford Biomedica
Click to Show/Hide
|
|||
| Indication | Macular degeneration [ICD-11: 9B78.3; ICD-10: H35.3; ICD-9: 362.5] | Phase 2 | [1] | |
| Company |
Oxford BioMedica plc
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Safety and biodistribution of an equine infectious anemia virus-based gene therapy, RetinoStat( ), for age-related macular degeneration. Hum Gene Ther. 2012 Sep;23(9):980-91. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.